Panwar Aru, Cheung Veronique Wan Fook, Lydiatt William M
Division of Head and Neck Surgical Oncology, University of Nebraska Medical Center, 981225 Nebraska Medical Center, Omaha, NE 68198-1225, USA; Head and Neck Surgical Oncology, Nebraska Methodist Hospital, 8303 Dodge St., Omaha, NE 68154, USA.
Division of Head and Neck Surgical Oncology, University of Nebraska Medical Center, 981225 Nebraska Medical Center, Omaha, NE 68198-1225, USA.
Hematol Oncol Clin North Am. 2015 Dec;29(6):1159-68. doi: 10.1016/j.hoc.2015.07.010. Epub 2015 Sep 9.
Supportive care and survivorship strategies in the management of head and neck squamous cell carcinoma (HNSCC) revolve around continued collaborative efforts aimed at early identification and intervention for locoregional disease recurrence, second primary malignancy, management of treatment-related side effects, and provision for psychosocial support. Development of evidence-based guidelines and optimization of these strategies is increasingly important in the setting of improved survival of patients with HNSCC because of a variety of diagnostic and therapeutic advances and evolving demographics of HNSCC patient population, specifically, p16-associated oropharyngeal squamous cell carcinoma.
头颈部鳞状细胞癌（HNSCC）管理中的支持性护理和生存策略围绕持续的协作努力展开，这些努力旨在对头颈部局部区域疾病复发、第二原发性恶性肿瘤进行早期识别和干预，处理治疗相关的副作用，并提供心理社会支持。鉴于HNSCC患者生存率的提高，由于各种诊断和治疗进展以及HNSCC患者群体（特别是p16相关口咽鳞状细胞癌）不断变化的人口统计学特征，制定基于证据的指南并优化这些策略变得越来越重要。
